Related references
Note: Only part of the references are listed.Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study
Lisa Eggebrecht et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
Aruna D. Pradhan et al.
AMERICAN HEART JOURNAL (2018)
The metabolism and significance of homocysteine in nutrition and health
Avinash Kumar et al.
NUTRITION & METABOLISM (2017)
Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor
Derek Klarin et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study
J. Klovaite et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study
Markus Herrmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - A prospective family cohort study in asymptomatic subjects
Anja B. U. Makelburg et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Overweight, obesity, and the risk of recurrent venous thromboembolism
Sabine Eichinger et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease - A randomized trial
Christine M. Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Homocysteine-lowering therapy and risk for venous thromboembolism - A randomized trial
Joel G. Ray et al.
ANNALS OF INTERNAL MEDICINE (2007)
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
Martin den Heijer et al.
BLOOD (2007)
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Homocysteine, MTHFR and risk of venous thrombosis:: a meta-analysis of published epidemiological studies
M Den Heijer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors
I Shai et al.
ATHEROSCLEROSIS (2004)
Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia
MR Fokkema et al.
CLINICAL CHEMISTRY (2003)
Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal investigation of thromboembolism etiology,(LITE)
AW Tsai et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis
R Clarke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
N Weiss et al.
VASCULAR MEDICINE (2002)
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia
RT Eberhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism -: More evidence from a case-control study
LJ Langman et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
